Equine gastric ulcer syndrome remained one of the most common and challenging conditions in equine practice. In this interactive panel webinar, Dr. David Rendle and Dr. Camilla Jamieson drew on published research and their clinical experience to answer practitioners’ questions about extended-release injectable omeprazole. Questions submitted by attendees in advance guided the discussion, which covered case selection, pharmacology, dosing intervals, injection site selection and reaction management, combination therapy, and appropriate treatment duration. Participants left with practical, evidence-based guidance they could apply directly to managing equine glandular and squamous gastric disease.